Sant Pau publishes Clinical Science
Researchers from the CIBER on Cardiovascular Diseases (CIBERCV) have analysed the contribution of a protein (the NOR-1 nuclear receptor) to the progression of hypertensive cardiac hypertrophy, thanks ...
Researchers from the CIBER on Cardiovascular Diseases (CIBERCV) have analysed the contribution of a protein (the NOR-1 nuclear receptor) to the progression of hypertensive cardiac hypertrophy, thanks ...
Dr. Israel Fernández Cadenas, from the Pharmacogenomics and Neurovascular Genetics Research Group at the Sant Pau Research Institute, is one of the 25 speakers who today presented their work at the R...
A Sant Paul's study of the factors that determine aortic diameter in families at high risk for abdominal aortic aneurysm (AAA) reveals two new candidate genes. The article was recently published in th...
The Complex Diseases Genomics Group of the Sant Pau Hospital Research Institute - IIB Sant Pau, led by Dr. José Manuel Soria, demonstrates, for the first time, which epigenetic mechanisms are involve...
Dr. Eduard Gallardo has been appointed group leader of the U762 CIBERER (Centre for Research on Rare Disease Networks) in Sant Pau, replacing Dr. Isabel Illa. This research group specializes in neurom...